This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Faulds, G. Articles by Arner, P. Search for Related Content PubMed PubMed Citation Articles by Faulds, G. Articles by Arner, P.

Mechanisms behind Lipolytic Catecholamine Resistance of Subcutaneous Fat Cells in the Polycystic Ovarian Syndrome

Departments of Medicine (G.F., M.R., H.W., P.A.) and Gynaecology (I.E.) at Huddinge University Hospital, Karolinska Institute, SE-141 86 Stockholm, Sweden

Address all correspondence and requests for reprints to: Peter Arner, M.D., Ph.D., Professor, Department of Medicine, M63, Huddinge University Hospital, Karolinska Institutet, SE-141 86 Stockholm, Sweden. E-mail: peter.arner{at}medhs.ki.se.

Lipolytic catecholamine resistance in sc fat cells is observed in polycystic ovarian syndrome (PCOS). The mechanisms behind this lipolysis defect were explored in vitro; sc fat cells were obtained from 10 young, nonobese PCOS women and from 14 matched, healthy control women. Fasting plasma glycerol levels were reduced by one third in PCOS (P < 0.05). Adipocytes of PCOS women were about 25% larger than in the controls (P < 0.05) and had 40% reduced noradrenaline-induced lipolysis (P < 0.05), which could be attributed to a 10-fold decreased ß₂-adrenoceptor sensitivity (P < 0.05) and low ability of cAMP to activate the protein kinase A (PKA)/hormone-sensitive lipase (HSL) complex (P < 0.05). In PCOS, the adipocyte protein content of ß₂-adrenoceptors, HSL, and the regulatory IIß-component of PKA were 70%, 55%, and 25% decreased, respectively (P < 0.001); but there was no change in the amount of the catalytic subunit of PKA or of ß₁-adrenoceptors. Thus, lipolytic catecholamine resistance of sc adipocytes in PCOS is probably attributable to a combination of decreased amounts of ß₂-adrenergic receptors, the regulatory IIß-component of PKA, and HSL. This may cause low in vivo lipolytic activity and enlarged sc fat cell size and promote later development of obesity in PCOS.

This work was supported by grants from Åke Wiberg Foundation, Tore Nilsson Foundation, Swedish Medical Society and Foundation for Scientific Work in Diabetes, Swedish Research Council, Swedish Heart and Lung Association, Swedish Diabetes Association, and Novo Nordic Fund.

G.F. and M.R. contributed equally to the study.

Abbreviations: AR, Adrenergic receptor; BMI, body mass index; HOMA, insulin sensitivity index; HSL, hormone-sensitive lipase; PCOS, polycystic ovarian syndrome; PKA, protein kinase A; PKAcat, the catalytic region of PKA.

This article has been cited by other articles:

				K.-M. Seow, Y.-L. Tsai, J.-L. Hwang, W.-Y. Hsu, L.-T. Ho, and C.-C. Juan Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome Hum. Reprod., August 1, 2009; 24(8): 1982 - 1988. [Abstract] [Full Text] [PDF]

				C. Moro, M. Pasarica, K. Elkind-Hirsch, and L. M. Redman Aerobic Exercise Training Improves Atrial Natriuretic Peptide and Catecholamine-Mediated Lipolysis in Obese Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2579 - 2586. [Abstract] [Full Text] [PDF]

				R. Homburg Androgen circle of polycystic ovary syndrome Hum. Reprod., July 1, 2009; 24(7): 1548 - 1555. [Abstract] [Full Text] [PDF]

				G. Mantovani, S. Bondioni, L. Alberti, L. Gilardini, C. Invitti, S. Corbetta, M. A. Zappa, S. Ferrero, A. G. Lania, S. Bosari, et al. Protein Kinase A Regulatory Subunits in Human Adipose Tissue: Decreased R2B Expression and Activity in Adipocytes From Obese Subjects Diabetes, March 1, 2009; 58(3): 620 - 626. [Abstract] [Full Text] [PDF]

				L. Manneras, S. Cajander, A. Holmang, Z. Seleskovic, T. Lystig, M. Lonn, and E. Stener-Victorin A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome Endocrinology, August 1, 2007; 148(8): 3781 - 3791. [Abstract] [Full Text] [PDF]

				T. Agustsson, M. Ryden, J. Hoffstedt, V. van Harmelen, A. Dicker, J. Laurencikiene, B. Isaksson, J. Permert, and P. Arner Mechanism of Increased Lipolysis in Cancer Cachexia Cancer Res., June 1, 2007; 67(11): 5531 - 5537. [Abstract] [Full Text] [PDF]

				M. Ryden, J. Jocken, V. van Harmelen, A. Dicker, J. Hoffstedt, M. Wiren, L. Blomqvist, A. Mairal, D. Langin, E. Blaak, et al. Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1847 - E1855. [Abstract] [Full Text] [PDF]

				K. J. McInnes, A. Corbould, E. R. Simpson, and M. E. Jones Regulation of Adenosine 5',Monophosphate-Activated Protein Kinase and Lipogenesis by Androgens Contributes to Visceral Obesity in an Estrogen-Deficient State Endocrinology, December 1, 2006; 147(12): 5907 - 5913. [Abstract] [Full Text] [PDF]